Dr. Keiffer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
925 Chestnut Street
925 Chestnut St
Philadelphia, PA 19107Phone+1 215-955-8874Fax+1 856-589-3989- Is this information wrong?
Education & Training
- Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 2013
- Sidney Kimmel Medical College at Thomas Jefferson University/TJUHFellowship, Hematology and Medical Oncology
Certifications & Licensure
- NJ State Medical License 2020 - 2025
- PA State Medical License 2013 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Palbociclib or Tazemetostat in Combination With CPX-351 for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia Start of enrollment: 2023 Aug 28
Roles: Contact
- Evaluating Navitoclax After Failure of Standard Treatments of Azacitidine or Decitabine and Venetoclax in Patients With Aggressive Myelodysplastic Syndrome Start of enrollment: 2023 Jan 12
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- A phase I study of the combination of palbociclib and dexamethasone for the treatment of relapsed or refractory B-cell acute lymphoblastic leukemia.Lindsay Wilde, Patrizia Porazzi, Rossana Trotta, Marco De Dominici, Neil Palmisiano, Gina Keiffer, Kaitlin Rancani, Kathryn Yingling, Bruno Calabretta, Margaret Kasner> ;Leukemia Research. 2023 Jun 1
- A Prospective, Randomized Trial Examining the Use of G-CSF Versus No G-CSF in Patients Post-Autologous Transplantation.Dolores Grosso, Benjamin Leiby, Lindsay Wilde, Matthew Carabasi, Joanne Filicko-O'Hara, William O'Hara, John L Wagner, Gina Mateja, Onder Alpdogan, Adam Binder, Margar...> ;Transplantation and Cellular Therapy. 2022 Dec 1
- Inpatient versus outpatient hypomethylating agent induction for acute myeloid leukemia as a predictor for survival.Chetan Jeurkar, Lindsay Wilde, Benjamin E. Leiby, Joshua Banks, Margaret Kasner, Gina Keiffer, Joanne Filicko-O'Hara, Neil Palmisiano> ;Leukemia Research. 2021 Apr 1
- Join now to see all
Authored Content
- Attempting to Answer Our Patients’ Hardest Questions at SOHO 2021September 2021
Professional Memberships
- Member
Hospital Affiliations
- Thomas Jefferson University HospitalsPhiladelphia, Pennsylvania
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: